Enovis

Banzai Signs 200 Customers in February

Retrieved on: 
Thursday, March 21, 2024
Enovis, Growth, Onesie

SEATTLE, March 21, 2024 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, celebrates the Company’s successful and continuous customer acquisitions efforts with the addition of 133 new and 67 reactivating customers during February 2024.

Key Points: 
  • SEATTLE, March 21, 2024 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, celebrates the Company’s successful and continuous customer acquisitions efforts with the addition of 133 new and 67 reactivating customers during February 2024.
  • Banzai’s newly added customers include Enovis , a leading medical technology company, Fluence , a Siemens and AES Company, Onsi , a leading financial technology company, Applied Value Group , a leading management consulting company, Nsight , a global technology consulting firm, Quickparts , a 3D manufacturing firm and ComboCurve , an energy analysis and solutions platform.
  • “Following our great January, we continue to see strong growth in customer wins,” said Joe Davy, CEO and Founder of Banzai.
  • “This demonstrates our strong continued vertical market execution across healthcare, consulting, and financial services.”

J. Kurt Jacobus, Ph.D. Joins CurvaFix Board of Directors

Retrieved on: 
Tuesday, March 5, 2024
Medical Devices, Health, Surgery, Other Health, General Health, Biotechnology, Acquisition, Champaign–Urbana metropolitan area, Bone fracture, Enovis, Mechanical, Foot, Doctor of Philosophy, Pelvis, NuVasive, University, Mechanical engineering, Patient, Anatomy, Science, Trauma, Research, Nursing

CurvaFix, Inc ., a developer of medical devices that deliver stable fixation for curved anatomy and poor bone quality, announced today the appointment of J. Kurt Jacobus, Ph.D., as the newest member of its Board of Directors.

Key Points: 
  • CurvaFix, Inc ., a developer of medical devices that deliver stable fixation for curved anatomy and poor bone quality, announced today the appointment of J. Kurt Jacobus, Ph.D., as the newest member of its Board of Directors.
  • “We are delighted to welcome Kurt to CurvaFix’s Board of Directors,” said Mark Foster, CEO at CurvaFix.
  • “His extensive experience and proven track record of success in the orthopedic medical device sector makes him an invaluable addition to our board.
  • “I am honored to join CurvaFix’s excellent Board of Directors,” said Dr. Jacobus.

Perdue Farms Announces Executive Leadership Changes

Retrieved on: 
Tuesday, December 19, 2023
Tyson Foods, Culture, Food safety, Acquisition, Perdue Farms, Value chain, Ford Motor Company, Red meat, Supply, SVP, Engineering, Enovis, Growth, CJ, Mead Johnson, Transport, Uecker, Management

Salisbury, MD, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Perdue Farms, a fourth-generation, family-owned U.S. food and agricultural products company, today announced senior leadership changes that underscore the company’s commitment to supply chain and operations optimization, talent acquisition and profitable growth.

Key Points: 
  • Salisbury, MD, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Perdue Farms, a fourth-generation, family-owned U.S. food and agricultural products company, today announced senior leadership changes that underscore the company’s commitment to supply chain and operations optimization, talent acquisition and profitable growth.
  • Gregg Uecker has joined Perdue Foods in the newly created position of Chief Supply Chain and Operations Officer.
  • Uecker comes to Perdue from CJ Schwan’s, where he was Executive Vice President of Global Supply Chain.
  • Julie Katigan has been promoted to Executive Vice President and Chief Human Resources Officer for Perdue Farms.

Enovis Announces Third Quarter 2023 Results and Raises Full-Year Outlook

Retrieved on: 
Tuesday, November 7, 2023
ENOV, DE, Growth, EBITDA, Acquisition, NYSE, Webcast, International, P&R, Retail, Recon, Enovis

Wilmington, DE, Nov. 07, 2023 (GLOBE NEWSWIRE) -- —Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the third quarter ended September 29, 2023. The Company will host an investor conference call and live webcast to discuss these results today at 8:00 am ET.

Key Points: 
  • Wilmington, DE, Nov. 07, 2023 (GLOBE NEWSWIRE) -- —Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the third quarter ended September 29, 2023.
  • The Company will host an investor conference call and live webcast to discuss these results today at 8:00 am ET.
  • Enovis’ third quarter net sales of $418 million grew 9% from the same quarter in 2022, including 6.2% organic sales per day growth.
  • Third quarter results reflect continued stability in P&R, above market growth in Recon, and the impact of recent acquisitions.

ENOVIS CORPORATION ANNOUNCES PRICING OF PRIVATE OFFERING OF $400 MILLION OF 3.875% CONVERTIBLE SENIOR NOTES DUE 2028

Retrieved on: 
Friday, October 20, 2023
Sale, NYSE, ENOV, Person, Acquisition, Interest, Exercise, Offering, External commercial borrowing, Debt-to-GDP ratio, Security (finance), Cryptocurrency, Enovis, Note

Wilmington, DE, Oct. 20, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) today announced the pricing of $400 million aggregate principal amount of 3.875% Convertible Senior Notes due 2028 (the “Notes”) in a private offering (the “Offering”).

Key Points: 
  • Wilmington, DE, Oct. 20, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) today announced the pricing of $400 million aggregate principal amount of 3.875% Convertible Senior Notes due 2028 (the “Notes”) in a private offering (the “Offering”).
  • When issued, the Notes will be senior unsecured obligations of Enovis and will rank equal in right of payment to the Company’s unsecured and unsubordinated indebtedness.
  • The Notes will mature on October 15, 2028, unless earlier repurchased, redeemed or converted in accordance with their terms prior to such date.
  • Enovis intends to use approximately $53.9 million of the net proceeds from the Offering to pay the cost of the capped call transactions.

Enovis Corporation Announces Proposed Private Offering of $400 Million of Convertible Senior Notes

Retrieved on: 
Thursday, October 19, 2023
Sale, NYSE, Convertible, ENOV, Person, Acquisition, Exercise, Offering, External commercial borrowing, Debt-to-GDP ratio, SEC Rule 144A, Security (finance), Enovis, Note

Wilmington, DE, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) today announced its intention to offer, subject to market conditions and other factors, $400 million aggregate principal amount of Convertible Senior Notes due 2028 (the “Notes”) in a private offering (the “Offering”).

Key Points: 
  • Wilmington, DE, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) today announced its intention to offer, subject to market conditions and other factors, $400 million aggregate principal amount of Convertible Senior Notes due 2028 (the “Notes”) in a private offering (the “Offering”).
  • If the initial purchasers exercise their option to purchase additional Notes, the Company expects to enter into additional capped call transactions with the option counterparties.
  • This activity could increase or reduce the size of any decrease in the market price of the Company’s common stock and/or the Notes.
  • Enovis intends to use a portion of the net proceeds from the Offering to pay the cost of the capped call transactions.

Enovis to Host Third Quarter 2023 Results Conference Call on November 7th

Retrieved on: 
Monday, October 16, 2023
NYSE, ENOV, International, Cryptocurrency, Auction, Enovis

Wilmington, DE, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will host an investor conference call and live webcast to discuss its third quarter 2023 financial results on Tuesday, November 7, 2023 at 8:00 a.m. Eastern Time and will issue a press release earlier that morning.

Key Points: 
  • Wilmington, DE, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will host an investor conference call and live webcast to discuss its third quarter 2023 financial results on Tuesday, November 7, 2023 at 8:00 a.m. Eastern Time and will issue a press release earlier that morning.
  • A presentation related to the call will be available at www.enovis.com in the “Investors” section.
  • Investors can access a live webcast via a link on the Enovis website.
  • A link to a replay of the call will also be available on the Enovis website later that day.

Boomi Introduces Boomi GPT, Further Accelerating Integration and Automation With Conversational AI

Retrieved on: 
Tuesday, October 3, 2023
Data Management, Security, Apps, Applications, Technology, Software, Networks, Artificial Intelligence, IDC, Learning, Enovis, Integration platform, Multimedia, Automation, Organization, Silicon, Hospital, Outline, Boomi, API, Medical device

Boomi™ , the intelligent connectivity and automation leader, today announced at its Silicon Valley Boomi World Tour , Boomi GPT, the first offering available in the Boomi AI suite, bringing a simple, conversational experience to the Boomi platform .

Key Points: 
  • Boomi™ , the intelligent connectivity and automation leader, today announced at its Silicon Valley Boomi World Tour , Boomi GPT, the first offering available in the Boomi AI suite, bringing a simple, conversational experience to the Boomi platform .
  • With Boomi GPT, organizations can harness the power of generative AI to integrate and automate faster than ever before, further democratizing innovation and accelerating business outcomes.
  • View the full release here: https://www.businesswire.com/news/home/20231003268398/en/
    Boomi Introduces Boomi GPT, Further Accelerating Integration and Automation With Conversational AI (Graphic: Business Wire)
    In every industry, companies are under intense pressure to innovate faster and achieve their boldest business ambitions.
  • Customers can use Boomi GPT’s natural language prompt to ask Boomi AI to build integrations, APIs, or master data models.

Enovis to Acquire LimaCorporate S.p.A.

Retrieved on: 
Monday, September 25, 2023
Allen & Overy, Surgeon, International, ENOV, 3D, J.P. Morgan & Co., Motion, EBITDA, Acquisition, Patient, Webcast, Growth, UBS, Hand, NYSE, Chair, Cryptocurrency, Enovis

Wilmington, DE, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”), an innovation-driven, medical technology growth company, today announced a definitive agreement to acquire LimaCorporate S.p.A. (“Lima”), a privately held global orthopedic leader focused on restoring motion through an innovative portfolio of implant solutions. The acquisition has an enterprise value of approximately €800 million, consisting of a €700 million cash payment at closing and €100 million in shares of Enovis common stock.

Key Points: 
  • Wilmington, DE, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”), an innovation-driven, medical technology growth company, today announced a definitive agreement to acquire LimaCorporate S.p.A. (“Lima”), a privately held global orthopedic leader focused on restoring motion through an innovative portfolio of implant solutions.
  • The acquisition has an enterprise value of approximately €800 million, consisting of a €700 million cash payment at closing and €100 million in shares of Enovis common stock.
  • Enovis will conduct a conference call and webcast with investors to discuss the transaction today, September 25th, 2023, at 8:30 AM ET.
  • A link to a replay of the call will also be available on the Enovis website later in the day.

EQT PRIVATE EQUITY TO SELL LIMACORPORATE TO ENOVIS: THE ITALIAN SITE IN SAN DANIELE DEL FRIULI WILL REMAIN THE FULCRUM OF PRODUCTION, BENEFITING FROM NEW INVESTMENTS

Retrieved on: 
Monday, September 25, 2023
Surgeon, Face, Printing, 3D, Emotions in Motion, Sale, EUR, EQT, Work, Patient, Investment, Motion, Engineering, Motivation, Headquarters, NYSE, Fine chemical, Management, Enovis, San Daniele del Friuli

UDINE, Italy, Sept. 25, 2023 /PRNewswire/ -- EQT Private Equity announces the sale of LimaCorporate to Enovis.

Key Points: 
  • UDINE, Italy, Sept. 25, 2023 /PRNewswire/ -- EQT Private Equity announces the sale of LimaCorporate to Enovis.
  • Founded in 1945 by the Lualdi family and headquartered in San Daniele del Friuli, Italy, LimaCorporate is a global orthopaedic implant manufacturer.
  • Its heritage of innovation is reflected in its industry-leading know-how in additive manufacturing, such as its proprietary Trabecular Titanium (TT) technology.
  • New investments will accelerate the completion of the new production building at the Headquarter in San Daniele del Friuli.